The herpes simplex virus (HSV) genome encodes receptors for the Fc domain of immunoglobulin G (IgG), which have been demonstrated on both infected cells and the virion envelope (3, 37) . The role that these receptors play in modulating the course of infection in vivo is unknown, but it is postulated that the Fc receptor (FcR) protects the virus or virus-infected cells from host immune attack. Previous studies have examined the protective role of the FcR by using nonimmune IgG, IgG aggregates, or antiviral IgG (1, 9, 13) . Dowler and Veltri showed that monomeric nonimmune IgG or purified Fc fragments protect virus from antibody neutralization (9) . Adler et al. demonstrated that IgG aggregates protect HSV type 1 (HSV-1)-infected cells from complement-mediated cytolysis or destruction by sensitized lymphocytes (1) . Recently, Frank and Friedman demonstrated that the HSV-1 FcR also binds anti-HSV IgG (13) . This occurs when the FcR binds the Fc end of an IgG molecule that is bound by its Fab end to its antigenic target. By allowing anti-HSV IgG to bind in this bipolar fashion, the FcR protects the virus from antibody-and complementmediated neutralization. Of interest, anti-HSV IgG binds to the FcR on infected cells at IgG concentrations 100-to 2,000-fold lower than required for binding nonimmune IgG (13) .
Several studies have addressed the structure of the HSV-1 FcR. Using affinity chromatography, Baucke and coworkers isolated an Fc-binding glycoprotein, designated gE, from HSV-1-infected cells (3, 30) . Recently, Johnson et al. coprecipitated glycoprotein I (gI) and gE in experiments using nonimmune IgG (19, 20 (15) . This fragment simian virus 40 enhancerlike sequences and into the M13 polylinker site of pSP64 to gener; (23, 36 (Fig. 1) . The MMTV LTR promote into the PstI and HinclI sites of the M13 polylir (10, 15 (Fig. 2) . The amount of IgG binding is reported as the relative intensity of fluorescence of infected cells incubated with IgG and conjugate compared with that of infected cells incubated with conjugate alone. Cells infected with strain F showed intense fluorescence ( Fig. 2A ; relative intensity of fluorescence, 14.3), whereas cells infected with either FgD3gal (gI mutant; Fig. 2B ) or -ENS (gE mutant; Fig. 2C ) bound little or no IgG (relative intensity of fluorescence, 0.97 or 1.19, respectively). When cells were infected with both FgDpgal and -ENS, the relative intensity of fluorescence was 14.7 ( Fig. 2D) IgG complexes. Cells infected with strain F consistently bound more IgG complexes than did those infected with strain NS. This finding suggests that strain variability in Fc-binding activity occurs.
To determine whether gI contributes to the binding of IgG complexes, endothelial cells were doubly infected with both a gE-negative mutant (-ENS) and a gI-negative mutant (FgD3gal) and compared with cells infected with the gI mutant alone (Fig. 3) . No significant difference in binding was detected, indicating that gI does not enhance the binding of IgG complexes.
(ii) A complementing cell line that expresses gE inducibly after infection with gE-negative mutants. As an additional approach to evaluate the roles of gE and gI in binding IgG complexes, cell clone LgE was developed. This clone inducibly expresses gE after infection with gE-negative mutants. This results from transcription of the cloned gE gene, which is stimulated by early regulatory proteins produced during HSV-1 infection. The roles of gE and gI in binding IgG complexes were evaluated by using a rosetting assay. As a control for nonspecific binding, L cells were infected with wild-type virus (strain NS) and incubated with unsensitized erythrocytes. No rosettes formed. L cells infected with -ENS failed to rosette IgG-sensitized erythrocytes (Fig. 5) . In contrast, LgE cells infected with -ENS bound significant amounts of EAIgG (Fig. 5) . Infected LgE cells expressed both gE and gI, whereas L cells infected with -ENS expressed only gI. These results further demonstrate that gE is essential for binding IgG complexes.
(iii) A complementing cell line that expresses gI inducibly after infection with gI-negative mutants. The VD60 clone, a gI-complementing cell line, was used to further investigate whether gI has a role in binding IgG complexes. VD60 and Vero cells were infected with FgDpgal and the parental wild-type strain F and assayed for rosetting of EAIgG (Fig.   6 ). Vero cells infected with FgD3gal (gE is expressed, but not gI) bound as much EAIgG as did VD60 cells infected with FgDpgal (gE and gI are both expressed). Furthermore, the amount of binding was similar to that of cells infected with parental strain F. As a control for nonspecific binding, Vero cells were infected with wild-type virus (strain NS) and examined for rosetting of unsensitized erythrocytes. No (Fig. 7A ). These cells also bound IgG complexes.
Rosettes formed to a degree consistent with the amount of gE expression (less than 1% of cells; Fig. 7B (19, 20 (13) . gE may be the FcR involved in this process. IgG bound in a bipolar fashion is less capable of antibody-and complement-mediated neutralization (13) .
FcRs have been identified on a number of other microorganisms, including HSV-2, cytomegalovirus, varicellazoster virus, Staphylococcus aureus, group A, C, and G streptococci, Schistosoma mansoni, and several Leishmania and Trypanosoma species (7, 11, 12, 21, 32-34, 38, 39) . Our observations concerning the HSV-1 FcR may have relevance in studying the FcRs of these other infectious agents.
